7210 Wareham Drive, Tampa, FL 33647
March 9, 2020 Based on our research over the past few decades, only about 3.4% of dieters prefer to visit a physician’s office, hospital or medical clinic for a weight loss program. 80-85% or so use a do-it-yourself program (retail meal replacements, OTC diet pills, online purchases), and the balance use a commercial chain or […]
Coronavirus Could Hurt Medical Weight Loss Programs Read More »
Jan. 2, 2020 U.S. News & World Report, the global authority in rankings and consumer advice, released its annual assessment of the year’s Best Diets. For the millions of Americans making health-related resolutions for the New Year, the Best Diets platform offers rankings, data and information on 35 diet plans to help people across the
U.S. News Ranks The Best Diets Read More »
October 3, 2019 Noom has developed a weight-loss app and a personalized meal-planning service it says already is used by 45 million people worldwide that helps overweight people make behavioral changes that can help them slim down. Danish drug maker Novo says it has completed an eight-month pilot that combined Noom’s behavior change programs with
Noom and Novo Nordisk Team Up – New Diet Service Read More »
May 1, 2019 Medifast, Inc. today reported financial results for the first quarter ended March 31, 2019. “Our strong start to the year was fueled by a record number of active earning OPTAVIA Coaches and increased coach productivity,” commented Dan Chard, Medifast’s CEO. “These achievements helped generate first quarter revenue and earnings above our expectations and
Medifast Reports Q1 Results Read More »
Nov. 7, 2018 — 3rd Quarter 2018 Highlights: Revenue of $139.2 million, an increase of 80.3% year-over-year Active earning Coaches of 22,600, an increase of 59.2% year-over-year Net income of $13.8 million, an increase of 106.1% year-over-year Earnings per diluted share (“EPS”) of $1.14, an increase of 107.3% year-over-year Dan Chard, Medifast’s CEO, said: …”We are
Medifast Reports Q3 Results – Stock Gets Crushed Read More »